BioSpace News Archive

In the trial, 396 patients with moderate-to-severe psychotic symptoms related to adult schizophrenia received either Nuplazid or placebo added to their current antipsychotic treatment. The patients receiving Nuplazid showed a consistent trend in symptom improvement but did not hit statistical significance on the primary endpoint.

Today, Civica Rx announced a five-year deal with London, UK-based Hikma Pharmaceuticals to manufacture and supply Civica’s members with 14 sterile injectable drugs as a private label distributor.

Sanofi will be responsible for leading the clinical program and funding all studies needed to support the over-the-counter switch in the United States and will also be responsible for the regulatory submissions.

At 96 weeks, 60% of the heavily pretreated HIV patients dosed with ViiV’s experimental treatment achieved virologic suppression.

Researchers with the Weizmann Institute of Science worked with mice with an ALS-like disease. They found that the course of the disease slowed after the mice received specific strains of gut microbes or substances that were secreted by the microbes. The results suggest that the microbiome may play a regulatory role in people with ALS.

Research recently published by researchers from The Scripps Research Institute in the Proceedings of the National Academy of Sciences found that exosomes play an integral role in the development of neurons and neural circuits. In addition, they are able to fix brain cells damaged by developmental disease.

Agency is expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD

Nurx, the health tech company addressing sensitive health needs and the leading online provider for birth control, is now available in Kentucky

The Medical Science Liaison Society (MSL Society), the only 501(c)(3) non-profit organization exclusively dedicated to advancing the global medical science liaison (MSL) profession, has announced that it will be holding its 7th Annual MSL Society Conference at the Venetian Hotel in Las Vegas from September 3-5, 2019.

Collaboration will drive innovation to eliminate well-known chemicals of concerns from essential healthcare supplies